“Keys, scumbag. It’s the universal symbol for keys.”

Mike Ehrmantraut, his hand outstretched to Walter White (Episode 1, Season 5, Breaking Bad)

 

Some gestures are easy to figure out. Others less so. Under Christmas trees around the world, the latest version of Xbox is waiting to take a crack at some of what may be the first signs of a new way to manipulate medical images.

Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International. The findings indicate the importance of monitoring patients for potential signs of bladder cancer to ensure early diagnosis and treatment.

The pursuit of an imaging tool to visualize the protein alpha-synuclein, the hallmark pathology of Parkinson's disease (PD), in the brain is the subject of a paper published today in theJournal of Parkinson's Disease by three researchers from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The Foundation has assembled and leads a consortium to develop a radioactive PET tracer that could lead to better therapies and quality of life for Parkinson's patients.

Monaco 5, the latest version of Elekta's Monaco treatment planning system has received 510(k) clearance from the US Food & Drug Administration, making it available for purchase and use in the United States.

Siemens Healthcare has announced that the Food and Drug Administration (FDA) has cleared the Magnetom Prisma, a 3 Tesla (3T) magnetic resonance imaging (MRI) scanner capable of extraordinarily high spatial and temporal resolution to achieve outstanding image quality, particularly in highly demanding applications.

Following public comment received in the fall of 2013, The Joint Commission has released new accreditation standards for diagnostic imaging services. Nearly all of these new standard Elements of Performance (EP) are slated to become effective in a half-year.

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography (FFDM) system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Piramal Imaging announced today the European Union's Committee for Medicinal Products for Human Use (CHMP) recommended approval of NeuraCeq (florbetaben 18F). The CHMP's recommendation will now be referred to the European Commission, for approval in the European Union (EU).

ViewRay Inc., a privately held medical device company, secured $30 million of funds to support the worldwide commercialization of the ViewRay system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now